SC Filed 2018-04-26 Event — SEC 0001193125-18-134207 →

Shin Nippon Biomedical Laboratories, Ltd. → Wave Life Sciences Ltd. WVE

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 25/100

Passive Schedule 13G filer baseline
Held by 1 tracked 13F institutional manager
Elevated short days-to-cover (6.5 DTC)
Short interest building (+14.1% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

21 transactions

16 buys · 4 sales · 1 awards/exercises

Issuer Cluster

10 13D/G filings on this issuer

9 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 6.53

21,167,722 shares short · +14.1% vs prior

Institutional Consensus · 2026-06-30

Held by elite portfolio managers

1 holder · $1K

Duquesne Family Office

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-10-05	RA CAPITAL MANAGEMENT, L.P.	director, 10%+ owner	Award	10,700	—	—
2026-10-05	RA CAPITAL MANAGEMENT, L.P.	director, 10%+ owner	Award	64,000	$3.75	$240K
2026-10-05	Verdine Gregory L.	director	Award	10,700	—	—
2026-10-05	Verdine Gregory L.	director	Award	64,000	$3.75	$240K
2026-10-05	Tan Aik Na	director	Award	10,700	—	—
2026-10-05	Tan Aik Na	director	Award	64,000	$3.75	$240K
2026-10-05	TAKANASHI KEN	director	Award	10,700	—	—
2026-10-05	TAKANASHI KEN	director	Award	64,000	$3.75	$240K
2026-10-05	CORRIGAN MARK	director	Award	10,700	—	—
2026-10-05	CORRIGAN MARK	director	Award	64,000	$3.75	$240K
2026-10-05	Rawcliffe Adrian	director	Award	10,700	—	—
2026-10-05	Rawcliffe Adrian	director	Award	64,000	$3.75	$240K
2026-10-05	Wagner Heidi L	director	Award	10,700	—	—
2026-10-05	Wagner Heidi L	director	Award	64,000	$3.75	$240K
2026-10-05	HENRY CHRISTIAN O	director	Award	10,700	—	—
2026-10-05	HENRY CHRISTIAN O	director	Award	64,000	$3.75	$240K
2026-08-12	Rawcliffe Adrian	director	Sale	12,700	$5.29	$67K
2026-08-11	Wagner Heidi L	director	Option exercise	7,000	$5.97	$42K
2026-08-11	Wagner Heidi L	director	Sale	7,000	$6.01	$42K
2026-08-11	TAKANASHI KEN	director	Sale	3,864	$6.01	$23K
2026-08-11	Tan Aik Na	director	Sale	432	$6.01	$3K

Other 13D/G Filings on Wave Life Sciences Ltd.

Filed	Form	Filer	Stake	Shares
2026-08-11	SCHEDULE 13D/A	RA CAPITAL MANAGEMENT, L.P.	—	34,314,406	view →
2024-10-01	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →
2022-08-12	SC	Shin Nippon Biomedical Laboratories, Ltd.	—	—	view →
2022-07-20	SC	Kagoshima Shinsangyo Sousei Investment Limited Partnership	—	—	view →
2021-11-12	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →
2021-08-18	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →
2019-02-20	SC	Shin Nippon Biomedical Laboratories, Ltd.	—	—	view →
2019-01-28	SC	RA CAPITAL MANAGEMENT, LLC	—	—	view →
2018-03-22	SC	Kagoshima Shinsangyo Sousei Investment Limited Partnership	—	—	view →

Other Filings by Shin Nippon Biomedical Laboratories, Ltd.

Filed	Form	Issuer	Stake	Shares
2022-08-12	SC	Wave Life Sciences Ltd. WVE	—	—	view →
2019-02-20	SC	Wave Life Sciences Ltd. WVE	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →